Gastroenterology — MCQs

A 31-year-old woman has experienced increasing malaise for the past 4 months. Physical examination yields no remarkable findings. Laboratory studies show total serum protein of 6.4 g/dL, albumin of 3.6 g/dL, total bilirubin of 1.4 mg/dL, AST of 67 U/L, ALT of 91 U/L, and alkaline phosphatase of 99 U/L. Results of serologic testing for HAV, HBV, and HCV are negative. Test results for ANA, anti-liver kidney microsome-1 and anti-smooth muscle antibody are positive. A liver biopsy is done; microscopically, there are minimal portal mononuclear cell infiltrates with minimal interface hepatitis and mild portal fibrosis. What is the most likely diagnosis?

Q777Medium

"Intestinal angina" is a symptom complex of the following:

Q778Medium

Which of the following features differentiates Rotor syndrome from Dubin-Johnson syndrome?

Q779Easy

What is the cause of chronic tropical pancreatitis?

Q780Medium

What is the best medical therapy for radiation proctitis among the following?

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 771: Intermittent dysphagia is caused by which of the following conditions?

A. Stricture
B. Achalasia cardia
C. Pharyngeal diverticulum (Correct Answer)
D. All of the above

Explanation: Dysphagia (difficulty swallowing) is clinically categorized based on its progression and the type of bolus (solids vs. liquids) involved. **1. Why Pharyngeal Diverticulum (Zenker’s Diverticulum) is correct:** A pharyngeal diverticulum is a structural abnormality (pouching) that causes **intermittent dysphagia**. The symptoms occur sporadically depending on whether the diverticulum is empty or filled with food. When filled, it compresses the esophagus, causing dysphagia, regurgitation of undigested food, and halitosis [1]. Because the pouch is not always full, the symptoms are not constant or strictly progressive. The gold standard for investigation is a barium swallow [1]. **2. Why the other options are incorrect:** * **A. Stricture (Esophageal Stricture):** This typically causes **progressive dysphagia**, initially for solids and later for liquids [1]. Once the lumen is narrowed, the obstruction is constant and worsening, not intermittent. * **B. Achalasia Cardia:** This is a motility disorder characterized by **progressive dysphagia** for both solids and liquids simultaneously [1]. While the severity may fluctuate slightly, it is generally a persistent, worsening condition due to the failure of the Lower Esophageal Sphincter (LES) to relax and progressive dilatation of the gullet [1]. **Clinical Pearls for NEET-PG:** * **Intermittent Dysphagia for Solids:** Highly suggestive of **Schatzki ring** or Esophageal Webs. * **Progressive Dysphagia (Solids → Liquids):** Suggests mechanical obstruction (Stricture if long history; Malignancy if short history/weight loss). * **Progressive Dysphagia (Solids + Liquids together):** Suggests a motility disorder (Achalasia Cardia or Diffuse Esophageal Spasm) [2]. * **Zenker’s Diverticulum** occurs at **Killian’s Dehiscence** (between the thyropharyngeus and cricopharyngeus muscles). The gold standard for diagnosis is a **Barium Swallow** [1].

Question 772: Which drug can cause complete histopathological resolution in patients with hepatitis B?

A. Cyclosporin
B. Prednisolone
C. Entecavir (Correct Answer)
D. None of the above

Explanation: The primary goal of treating Chronic Hepatitis B (CHB) is to prevent disease progression to cirrhosis and hepatocellular carcinoma. **Entecavir (Option C)** is a potent nucleoside analogue that inhibits HBV DNA polymerase [1]. Long-term therapy with Entecavir (and Tenofovir) not only achieves profound viral suppression and biochemical normalization but has been clinically proven to result in **histological improvement** and **regression of fibrosis/cirrhosis** [1]. Studies (notably by Chang et al.) demonstrated that long-term Entecavir treatment leads to a reduction in the Ishak fibrosis score and can result in near-complete histopathological resolution of necroinflammation. **Why other options are incorrect:** * **Cyclosporin (Option A):** This is an immunosuppressant used in transplants and autoimmune conditions. It does not have antiviral activity against HBV; in fact, immunosuppressants can trigger **HBV reactivation**, leading to fulminant hepatic failure. * **Prednisolone (Option B):** Corticosteroids suppress the immune response. While they might transiently lower transaminases, they increase viral replication. Withdrawal of steroids can cause a "transaminase flare" and does not lead to histopathological resolution of the underlying viral infection. **High-Yield Pearls for NEET-PG:** * **First-line agents for CHB:** Entecavir, Tenofovir (TDF/TAF), and Pegylated Interferon-alpha [2]. * **Entecavir's niche:** It is preferred in patients with renal impairment (over TDF) but has a high failure rate in patients already resistant to Lamivudine (due to shared resistance pathways). * **Histological "Reversal":** HBV is one of the few conditions where established cirrhosis is considered potentially reversible with long-term, effective antiviral therapy. * **Monitoring:** The most sensitive indicator of treatment response is the disappearance of HBV DNA (Viral Load) [3].

Question 773: All of the following are features of secretory diarrhea, except?

A. It is painless
B. It reduces with fasting (Correct Answer)
C. Stool volume is > 1L /day
D. Stool osmotic gap is normal

Explanation: ### Explanation The key to distinguishing types of diarrhea in NEET-PG lies in understanding the pathophysiology of water and electrolyte movement in the gut [1]. **Why "It reduces with fasting" is the correct answer:** Secretory diarrhea is caused by the active secretion of electrolytes (mainly $Cl^-$ or $HCO_3^-$) into the intestinal lumen, which drags water along with it [1]. This process is independent of food intake. Therefore, **secretory diarrhea persists even during fasting.** In contrast, **osmotic diarrhea** (e.g., lactose intolerance) improves or stops with fasting because the unabsorbed solutes that pull water into the lumen are no longer being ingested [2]. **Analysis of Incorrect Options:** * **Option A (Painless):** Secretory diarrhea is typically painless and watery. It lacks the cramping or tenesmus associated with inflammatory or dysenteric diarrhea. * **Option C (Stool volume > 1L/day):** Secretory diarrhea is characterized by high-volume output, often exceeding 1 liter per day (e.g., in Cholera or VIPoma) [1]. * **Option D (Stool osmotic gap is normal):** In secretory diarrhea, the fecal osmolality is accounted for by electrolytes ($Na^+$ and $K^+$). The **Stool Osmotic Gap (SOG)** is calculated as: $290 - 2 \times (Stool\ Na^+ + Stool\ K^+)$. In secretory diarrhea, the SOG is **low/normal (< 50 mOsm/kg)**, whereas in osmotic diarrhea, it is high (> 125 mOsm/kg). **High-Yield Clinical Pearls for NEET-PG:** 1. **Classic Causes:** Cholera (Vibrio toxin), VIPoma (WDHA syndrome: Watery Diarrhea, Hypokalemia, Achlorhydria), and Carcinoid syndrome [1]. 2. **Stool Osmotic Gap:** * **< 50 mOsm/kg:** Secretory Diarrhea. * **> 125 mOsm/kg:** Osmotic Diarrhea. 3. **VIPoma (Verner-Morrison Syndrome):** Often presents with massive secretory diarrhea (up to 5L/day) and is a classic "painless" diarrhea scenario.

Question 774: The Child-Pugh score is used for assessing the severity of which condition?

A. Hepatic encephalopathy
B. Uremic encephalopathy
C. Chronic liver disease (Correct Answer)
D. Head injury

Explanation: The **Child-Pugh score** (also known as the Child-Turcotte-Pugh score) is a validated clinical tool used to assess the prognosis and severity of **Chronic Liver Disease (CLD)**, particularly cirrhosis [1]. It helps clinicians predict mortality rates and determine the necessity of liver transplantation. ### Why Option C is Correct: The score evaluates liver function based on five parameters (mnemonic: **ABCDE**): 1. **A**lbumin (Serum levels) [1] 2. **B**ilirubin (Total levels) [1] 3. **C**oagulation (INR/Prothrombin Time) [1] 4. **D**egree of Ascites [2] 5. **E**ncephalopathy (Grade) [2] Patients are categorized into **Class A** (5–6 points; well-compensated), **Class B** (7–9 points; significant functional compromise), or **Class C** (10–15 points; decompensated/severe). ### Why Other Options are Incorrect: * **A. Hepatic Encephalopathy:** While this is a *component* of the Child-Pugh score, the score itself assesses the overall liver status, not just the encephalopathy [2]. Encephalopathy is graded separately using the **West Haven Criteria** [3]. * **B. Uremic Encephalopathy:** This is a complication of renal failure. Renal function is notably **absent** from the Child-Pugh score (it is, however, included in the MELD score) [2]. * **D. Head Injury:** Severity is assessed using the **Glasgow Coma Scale (GCS)**. ### High-Yield Clinical Pearls for NEET-PG: * **MELD Score (Model for End-Stage Liver Disease):** Uses Bilirubin, Creatinine, and INR. It is preferred over Child-Pugh for prioritizing patients on liver transplant waiting lists [2]. * **Limitation:** The Child-Pugh score is subjective regarding the grading of ascites and encephalopathy [2]. * **Surgical Risk:** Child-Pugh Class C patients have an extremely high perioperative mortality rate (approx. 80%) and are generally contraindicated for elective non-cardiac surgery.

Question 775: What is the most common cause of chronic pancreatitis?

A. Alcohol (Correct Answer)
B. Gallstones
C. Tropical pancreatitis
D. ERCP

Explanation: **Explanation:** **1. Correct Answer: A. Alcohol** Alcohol consumption is the **most common cause** of chronic pancreatitis worldwide, accounting for approximately 70–80% of cases in adults [1]. The pathophysiology involves the "toxic-metabolic" effect of ethanol, which increases the protein concentration of pancreatic secretions. This leads to the formation of protein plugs, which subsequently calcify (forming stones), causing ductal obstruction, chronic inflammation, and irreversible parenchymal fibrosis [1]. **2. Analysis of Incorrect Options:** * **B. Gallstones:** While gallstones are the **most common cause of acute pancreatitis**, they rarely cause chronic pancreatitis. Chronic pancreatitis requires long-term, repeated injury; gallstones typically cause discrete, episodic obstructive events. * **C. Tropical pancreatitis:** This is a specific form of idiopathic juvenile chronic calcific pancreatitis seen in developing countries (like parts of Southern India) [1]. While significant in certain demographics, it is not as common globally or nationally as alcoholic pancreatitis. * **D. ERCP:** Endoscopic Retrograde Cholangiopancreatography is a common cause of **iatrogenic acute pancreatitis**, but it does not lead to the chronic, progressive fibro-inflammatory changes seen in chronic pancreatitis. **3. NEET-PG High-Yield Pearls:** * **Classic Triad:** Pancreatic calcifications (most specific), steatorrhea, and diabetes mellitus (found in only 20-30% of patients). * **Most common symptom:** Epigastric pain radiating to the back [1]. * **Investigation of Choice:** **MRCP** is the most sensitive non-invasive test; **CT scan** is best for visualizing calcifications [1]. * **TIGAR-O Classification:** A mnemonic for etiologies (Toxic-metabolic, Idiopathic, Genetic, Autoimmune, Recurrent/Severe acute, Obstructive). * **Smoking:** Now recognized as an independent risk factor that acts synergistically with alcohol [1].

Question 776: A 31-year-old woman has experienced increasing malaise for the past 4 months. Physical examination yields no remarkable findings. Laboratory studies show total serum protein of 6.4 g/dL, albumin of 3.6 g/dL, total bilirubin of 1.4 mg/dL, AST of 67 U/L, ALT of 91 U/L, and alkaline phosphatase of 99 U/L. Results of serologic testing for HAV, HBV, and HCV are negative. Test results for ANA, anti-liver kidney microsome-1 and anti-smooth muscle antibody are positive. A liver biopsy is done; microscopically, there are minimal portal mononuclear cell infiltrates with minimal interface hepatitis and mild portal fibrosis. What is the most likely diagnosis?

A. a1-Antitrypsin deficiency
B. Autoimmune hepatitis (Correct Answer)
C. Chronic alcoholism
D. HDV infection

Explanation: **Explanation:** The clinical presentation and laboratory findings are classic for **Autoimmune Hepatitis (AIH)**. The patient is a young female (typical demographic) presenting with chronic malaise and elevated transaminases (AST/ALT). The definitive clues are the positive serological markers: **ANA (Anti-nuclear antibody)**, **ASMA (Anti-smooth muscle antibody)**, and **Anti-LKM-1 (Anti-liver kidney microsome-1)** [1]. Histologically, the presence of **interface hepatitis** (inflammation at the portal-parenchymal interface) and mononuclear cell infiltrates are hallmark features of AIH [1]. **Why other options are incorrect:** * **α1-Antitrypsin deficiency:** Typically presents with pulmonary emphysema and liver cirrhosis. Diagnosis is confirmed by low serum α1-antitrypsin levels and PAS-positive, diastase-resistant globules on biopsy. * **Chronic alcoholism:** Usually presents with an AST:ALT ratio > 2:1 and elevated GGT. Histology would show macrovesicular steatosis, Mallory-Denk bodies, and neutrophilic infiltration, rather than mononuclear interface hepatitis. * **HDV infection:** Hepatitis D requires a co-existing or pre-existing HBV infection (HBsAg positive). This patient tested negative for HBV serology. **High-Yield Pearls for NEET-PG:** * **Type 1 AIH:** Most common; characterized by positive **ANA** and/or **ASMA**. * **Type 2 AIH:** More common in children/adolescents; characterized by **Anti-LKM-1** or **Anti-LC1** antibodies. * **Histology Gold Standard:** Interface hepatitis (formerly called "piecemeal necrosis") and plasma cell-rich infiltrates [1]. * **Treatment:** Highly responsive to corticosteroids (Prednisolone) and Azathioprine [1].

Question 777: "Intestinal angina" is a symptom complex of the following:

A. Postprandial abdominal pain, weight loss, acute mesenteric vessel occlusion
B. Postprandial abdominal pain, weight loss, chronic mesenteric vessel occlusion (Correct Answer)
C. Pre-prandial abdominal pain, weight loss, chronic mesenteric vessel occlusion
D. Postprandial abdominal pain, weight gain, acute mesenteric vessel occlusion

Explanation: **Explanation:** **Intestinal Angina** (Chronic Mesenteric Ischemia) is a clinical syndrome caused by inadequate blood supply to the bowel, typically due to atherosclerotic narrowing of at least two of the three major mesenteric arteries (Celiac, SMA, or IMA). 1. **Why Option B is Correct:** * **Postprandial Pain:** Just as cardiac angina occurs when the heart's oxygen demand exceeds supply during exertion, intestinal angina occurs when the metabolic demand of the gut increases during digestion. Pain typically starts 15–30 minutes after a meal. * **Weight Loss:** This is a hallmark feature. Patients develop **"sitophobia"** (fear of eating) because food triggers intense pain, leading to voluntary starvation and significant weight loss. * **Chronic Occlusion:** Unlike acute events, this is a slow, progressive atherosclerotic process allowing for some collateral circulation, which prevents immediate bowel infarction but causes episodic ischemia. 2. **Why Other Options are Incorrect:** * **Option A & D:** **Acute** mesenteric vessel occlusion presents as a surgical emergency with "pain out of proportion to physical findings," sudden onset, and rapid progression to bowel gangrene, rather than a chronic "angina" pattern [1]. * **Option C:** The pain is **postprandial**, not pre-prandial, because the ischemic trigger is the increased blood flow requirement for digestion. * **Option D:** Weight **gain** is impossible as the patient avoids food to prevent pain. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Postprandial pain, weight loss, and an abdominal bruit (found in ~50% of cases). * **Gold Standard Diagnosis:** CT Angiography (CTA) or Conventional Angiography. * **Risk Factors:** Elderly patients with a history of smoking, hypertension, or peripheral vascular disease (PVD). * **Management:** Revascularization (Endovascular stenting or surgical bypass) [1].

Question 778: Which of the following features differentiates Rotor syndrome from Dubin-Johnson syndrome?

A. Liver patients with Rotor syndrome have no increased pigmentation and appear normal.
B. In Rotor syndrome, the gallbladder is usually visualized on cholecystography.
C. Total urinary coproporphyrin is substantially increased in Rotor syndrome.
D. The fraction of coproporphyrin I in urine is elevated, usually more than 80% of the total in Rotor syndrome. (Correct Answer)

Explanation: Both **Dubin-Johnson Syndrome (DJS)** and **Rotor Syndrome (RS)** are autosomal recessive conditions causing conjugated hyperbilirubinemia [1]. Differentiating them is a classic high-yield topic for NEET-PG. ### **Explanation of the Correct Answer** **Option D is correct.** In normal individuals, Coproporphyrin III is the predominant isomer in urine. In both DJS and RS, the **total** urinary coproporphyrin levels are elevated. However, the **fractional distribution** is the key differentiator: * **Dubin-Johnson:** Total coproporphyrin is normal/slightly high, but **>80% is Coproporphyrin I**. * **Rotor Syndrome:** Total coproporphyrin is **markedly increased** (3–5 fold), but the Coproporphyrin I fraction is typically **less than 70%** (usually around 25-50%). * *Note: While the question marks Option D as correct, in clinical practice, the >80% Coproporphyrin I fraction is actually the hallmark of Dubin-Johnson. In Rotor, the distinguishing feature is the massive increase in **total** urinary coproporphyrin.* ### **Why Other Options are Incorrect** * **Option A:** While true that RS livers lack pigmentation (unlike the "Black Liver" of DJS), this is a histological/gross finding, not the primary biochemical differentiator used in exams. * **Option B:** In Rotor Syndrome, the gallbladder **is visualized** on oral cholecystography. It is **not visualized** in Dubin-Johnson. * **Option C:** Total urinary coproporphyrin is indeed increased in Rotor, but this option is less specific than the isomer fraction analysis for differentiation. ### **High-Yield Clinical Pearls for NEET-PG** | Feature | Dubin-Johnson Syndrome | Rotor Syndrome | | :--- | :--- | :--- | | **Defect** | MRP2 mutation (canalicular transport) [1] | OATP1B1/B3 (sinusoidal uptake) | | **Liver Appearance** | **Black Liver** (Melanin-like pigment) | Normal appearance | | **Oral Cholecystography** | Gallbladder **NOT** visualized | Gallbladder **IS** visualized | | **Urinary Coproporphyrin** | Normal total; **>80% Isomer I** | **High total**; <70% Isomer I | | **Epinephrine Test** | May trigger jaundice | No effect |

Question 779: What is the cause of chronic tropical pancreatitis?

A. Parasitic infection
B. Cassava ingestion (Correct Answer)
C. Idiopathic
D. Genetic

Explanation: **Explanation:** **Tropical Chronic Pancreatitis (TCP)** is a specific form of chronic calcific non-alcoholic pancreatitis prevalent in tropical regions (like Southern India) [1]. **Why Cassava Ingestion is the correct answer:** The most widely accepted environmental hypothesis for TCP is the consumption of **Cassava (Tapioca)** [1]. Cassava contains **cyanogenic glycosides** (such as linamarin). In malnourished individuals with low intake of sulfur-containing amino acids (methionine/cysteine), the body fails to detoxify cyanide into thiocyanate. This leads to the accumulation of toxic cyanide metabolites, which cause free radical injury to the pancreatic acinar cells, resulting in chronic inflammation and extensive intraductal calcification. **Analysis of Incorrect Options:** * **A. Parasitic infection:** While parasites like *Ascaris lumbricoides* or *Clonorchis sinensis* can cause acute pancreatitis or biliary obstruction, they are not the primary etiological factor for the chronic tropical variant. * **C. Idiopathic:** While many cases of chronic pancreatitis are idiopathic, "Tropical Pancreatitis" is a distinct clinical entity traditionally linked to dietary toxins like cassava. * **D. Genetic:** Genetic mutations (specifically the **SPINK1 mutation**) are strongly associated with **Fibrocalculous Pancreatic Diabetes (FCPD)**, which is considered a late stage of TCP. However, the classical "cause" cited in traditional teaching and exams for the tropical variant remains the dietary toxin (Cassava). **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Abdominal pain, Steatorrhea, and Diabetes Mellitus. * **FCPD:** When TCP is associated with diabetes, it is called Fibrocalculous Pancreatic Diabetes. * **Imaging:** Characterized by **large, "star-shaped" intraductal calculi** on X-ray or CT. * **Genetic Link:** The **SPINK1 gene** (serine protease inhibitor Kazal-type 1) mutation is the most common genetic association in Indian patients. * **Risk:** These patients have a significantly higher risk of developing **Pancreatic Adenocarcinoma**.

Question 780: What is the best medical therapy for radiation proctitis among the following?

A. Formalin application
B. Sucralfate enema (Correct Answer)
C. 5-Aminosalicylic acid enema
D. Steroid enema

Explanation: **Explanation:** Radiation proctitis is a common complication following pelvic radiotherapy (e.g., for prostate or cervical cancer). It is categorized into acute (within 3 months) and chronic phases. **Why Sucralfate Enema is the Correct Answer:** Sucralfate is a basic aluminum salt of sulfated sucrose. When administered as an enema, it binds to the injured mucosa and forms a protective physical barrier (a "paste") over the friable, telangiectatic vessels. It also stimulates the local production of prostaglandins and epidermal growth factor, which promotes mucosal healing. Clinical trials have demonstrated that **sucralfate enemas are superior to anti-inflammatory agents** (like steroids or 5-ASA) in reducing rectal bleeding and improving mucosal appearance in chronic radiation proctitis. **Analysis of Incorrect Options:** * **Formalin application (Option A):** While highly effective for refractory bleeding, it is a **chemical cauterization** procedure, not a "medical therapy." It is typically reserved for cases where enemas fail. * **5-Aminosalicylic acid (5-ASA) enema (Option C):** Although used in Inflammatory Bowel Disease (IBD), 5-ASA has shown **minimal to no benefit** in radiation proctitis because the underlying pathology is ischemia and fibrosis, not primary idiopathic inflammation. * **Steroid enema (Option D):** Similar to 5-ASA, steroids are generally **ineffective** for chronic radiation proctitis [1] as the condition is characterized by obliterative endarteritis rather than active neutrophilic inflammation. **NEET-PG High-Yield Pearls:** * **Pathology:** Chronic radiation proctitis is characterized by **obliterative endarteritis** leading to mucosal ischemia and neovascularization (telangiectasias). * **First-line Medical Therapy:** Sucralfate enemas. * **First-line Interventional Therapy:** Argon Plasma Coagulation (APC) is the most common and effective endoscopic treatment. * **Refractory Cases:** Formalin (4% solution) application or Hyperbaric Oxygen Therapy.

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free